Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propan-1-ol (frequently misspelled as propanolol in some clinical trial documentation) is a primary alcohol used as a topical antiseptic and disinfectant. In clinical studies sponsored by the Centro Ortopédico y Quirúrgico del Pie, a 60% aqueous solution of propan-1-ol serves as the reference standard for surgical hand antisepsis to evaluate the reduction of bacterial load and the prevention of surgical site infections. Its mechanism of action involves the non-specific denaturation of microbial proteins and the disruption of cytoplasmic membranes, leading to rapid bactericidal effects against a broad spectrum of vegetative bacteria, fungi, and viruses. While propanolol is a well-known beta-blocker, the context of its use at a 60% concentration for hand washing in surgical settings confirms that the substance intended is the antiseptic alcohol propan-1-ol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propan-1-ol.